Abstract:Introduction: Renal transplantation improves the life expectancy and quality of life of end-stage renal patients. Due to the development of immunosuppressive drugs, the results of short-term renal transplantation have improved significantly, but the long-term survival rate of renal transplantation has hardly changed in the past few decades. Interstitial fibrosis is an important cause of graft loss in chronic allograft renal injury. CD40-CD154 costimulatory pathway block can inhibit T cell activation and prolong the survival of allografts in a variety of transplantation models. In this study, we found that the single use of MR1 (CD154 antibody) can significantly reduce the fibrosis of transplanted kidney. Method: The kidney of BALB/c mice was transplanted into C57BL6/J recipient by orthotopic transplantation. The contralateral kidney of the recipient was removed 1-3 days after transplantation. The MR1 treatment group was intraperitoneally injected with 500ug of MR1 antibody on the day of operation, and the control group was given normal saline at the same time. After 30 days, serum was collected to measure the blood creatinine. The kidney was obtained after cardiac perfusion. PAS staining was used to detect renal injury. The number of T lymphocytes and macrophages and the expression of a-SMA in the transplanted kidney were analyzed by flow cytometry. Sirius red and gomori trichrome staining were used to detect fibrosis. The colocalization of macrophages and a-SMA was detected by multiple immunofluorescence. Results: It was found that serum creatinine from MR1 treatment group was significantly lower than control group. Compared with control group, MR1 treated mice also showed milder renal histological lesions that the loss of brush border of proximal tubules, tubular necrosis, tubular atrophy, protein casting and cell infiltration at the cortical medullary junction were much lower. Sirius red and gomori trichrome staining showed that MR1 treatment group significantly reduced the fibrosis of transplanted kidney. RT-PCR showed that the expressions of collagen deposition related proteins such as ColI and FN mRNA were up-regulated in the control group. Further immunohistochemistry analysis showed that the number of infiltrated macrophages in the MR1 treatment group decreased significantly compared to control group. Through flow cytometry analysis, it was found that the number of macrophages secreting a-SMA in control group were significantly higher than those in MR1 treatment group. The FACS results showed that 92.7%± 2.8% of the infiltrating macrophages were M2 type, and they were all derived from the recipients. Immunofluorescence experiment also confirmed this result. Conclusion: MR1 significantly reduced the fibrosis in kidney graft which may due to less infiltration of M2 macrophages and less a-SMA+ macrophages. National key research and development program 2019YFA0110703. Natural Science Foundation of Hunan Province, China (Grant No.:2021JJ31018).

Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury.

Atg5 Deficiency in Macrophages Protects Against Kidney Fibrosis Via the CCR6-CCL20 Axis

Inflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis

Intragraft immune cells: accomplices or antagonists of recipient-derived macrophages in allograft fibrosis?

The Role of Macrophages in the Development of Human Renal Allograft Fibrosis in the First Year after Transplantation

The Role of the Macrophage-to-myofibroblast Transition in Renal Fibrosis

Macrophages: versatile players in renal inflammation and fibrosis

TGF-β/Smad3 Signalling Regulates the Transition of Bone Marrow-Derived Macrophages into Myofibroblasts During Tissue Fibrosis.

Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model.

Macrophage-Induced Pro-Fibrotic Gene Expression in Tubular Cells after Ischemia/Reperfusion Is Paralleled but Not Directly Mediated by C5a/C5aR1 Signaling

The role of macrophages in fibrosis of chronic kidney disease

The Role of Macrophages in Kidney Fibrosis

Macrophages Regulate Renal Fibrosis Through Modulating TGFβ Superfamily Signaling

412.10: Blocking of the CD40-CD154 Pathway Inhibits Macrophage Infiltration and Reduces Fibrosis After Renal Transplantation

The study of effect of Human macrophage polarization on Mouse Pericyte-to-Myofibroblast Transition in vitro

240.7: Macrophages and Different Subtypes Infiltrated in Kidney Allografts with Antibody-Mediated Rejection

FOS+ Macrophages Promote Chronic Rejection of Cardiac Transplantation

MicroRNA-874-3p/ADAM (A Disintegrin and Metalloprotease) 19 Mediates Macrophage Activation and Renal Fibrosis After Acute Kidney Injury

WNT-dependent interaction between inflammatory fibroblasts and FOLR2+ macrophages promotes fibrosis in chronic kidney disease

Identification of a Novel ECM Remodeling Macrophage Subset in AKI to CKD Transition by Integrative Spatial and Single-Cell Analysis

Inflammatory macrophages switch to CCL17‐expressing phenotype and promote peritoneal fibrosis